58 related articles for article (PubMed ID: 30639877)
21. Exploring the link between cancer policies and cancer survival: a comparison of International Cancer Benchmarking Partnership countries.
Nolte E; Morris M; Landon S; McKee M; Seguin M; Butler J; Lawler M
Lancet Oncol; 2022 Nov; 23(11):e502-e514. PubMed ID: 36328024
[TBL] [Abstract][Full Text] [Related]
22. International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
Araghi M; Fidler-Benaoudia M; Arnold M; Rutherford M; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Gavin A; Kozie S; Little A; Møller B; St Jacques N; Tervonen H; Walsh P; Woods R; O'Connell DL; Baldwin D; Elwood M; Siesling S; Bray F; Soerjomataram I; ; ; ; ;
Thorax; 2022 Apr; 77(4):378-390. PubMed ID: 34282033
[TBL] [Abstract][Full Text] [Related]
23. A comparison of outcomes and survival between Victoria and Denmark in lung cancer surgery: opportunities for international benchmarking.
Stenger M; Jakobsen E; Wright G; Zalcberg J; Stirling RG
ANZ J Surg; 2022 May; 92(5):1050-1055. PubMed ID: 34676962
[TBL] [Abstract][Full Text] [Related]
24. The size of the prize for earlier diagnosis of cancer in England.
Richards MA
Br J Cancer; 2009 Dec; 101 Suppl 2(Suppl 2):S125-9. PubMed ID: 19956156
[TBL] [Abstract][Full Text] [Related]
25. The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival.
Miranda-Filho A; Bray F; Charvat H; Rajaraman S; Soerjomataram I
Cancer Epidemiol; 2020 Dec; 69():101802. PubMed ID: 32942139
[TBL] [Abstract][Full Text] [Related]
26. A way to explore the existence of "immortals" in cancer registry data - An illustration using data from ICBP SURVMARK-2.
Andersson TM; Rutherford MJ; Myklebust TÅ; Møller B; Arnold M; Soerjomataram I; Bray F; Elkader HA; Engholm G; Huws D; Little A; Shack L; Walsh PM; Woods RR; Parkin DM; Lambert PC
Cancer Epidemiol; 2022 Feb; 76():102085. PubMed ID: 34954495
[TBL] [Abstract][Full Text] [Related]
27. Another year over, and a new one is up for highest impact!
Sakai D; Alini M; Mauck R
JOR Spine; 2021 Dec; 4(4):e1190. PubMed ID: 35005452
[No Abstract] [Full Text] [Related]
28. Evaluation of the Effect of Carvedilol in Preventing Right Ventricular Dysfunction in Breast Cancer Patients Receiving Anthracycline.
Karvandi M; Ghadyani M; Mohebbi N; Tabarraee M; Salari S
Adv Biomed Res; 2023; 12():5. PubMed ID: 36926423
[TBL] [Abstract][Full Text] [Related]
29. Trends in survival for cancer patients aged 65 years or over from 1995 to 2014 in the United States: A population-based study.
An L; Ju W; Zheng R; Zeng H; Zhang S; Chen R; Sun K; Li L; Wang S; Wei W
Cancer Med; 2023 Mar; 12(5):6283-6293. PubMed ID: 36366749
[TBL] [Abstract][Full Text] [Related]
30. Paradoxes of breast cancer incidence and mortality in two corners of Europe.
Roginski M; Sifaki-Pistolla D; Stomby A; Velivasaki G; Faresjö T; Lionis C; Faresjö Å
BMC Cancer; 2022 Nov; 22(1):1123. PubMed ID: 36319987
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Whole Brain Radiotherapy among Lung Cancer Patients with Brain Metastases in Relation to Health Care Level and Survival.
Frisk G; Helde Frankling M; Warnqvist A; Björkhem-Bergman L; Hedman M
Life (Basel); 2022 Apr; 12(4):. PubMed ID: 35455016
[TBL] [Abstract][Full Text] [Related]
32. Five ways to improve international comparisons of cancer survival: lessons learned from ICBP SURVMARK-2.
Andersson TM; Myklebust TÅ; Rutherford MJ; Møller B; Arnold M; Soerjomataram I; Bray F; Parkin DM; Lambert PC
Br J Cancer; 2022 May; 126(8):1224-1228. PubMed ID: 35058590
[TBL] [Abstract][Full Text] [Related]
33. Examining the Landscape of Prognostic Factors and Clinical Outcomes for Cancer Control.
Giuliani ME; Giannopoulos E; Gospodarowicz MK; Broadhurst M; O'Sullivan B; Tittenbrun Z; Johnson S; Brierley J
Curr Oncol; 2021 Dec; 28(6):5155-5166. PubMed ID: 34940071
[TBL] [Abstract][Full Text] [Related]
34. Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis.
Poon MTC; Sudlow CLM; Figueroa JD; Brennan PM
Sci Rep; 2020 Jul; 10(1):11622. PubMed ID: 32669604
[TBL] [Abstract][Full Text] [Related]
35. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
[TBL] [Abstract][Full Text] [Related]
36. Multilevel Approaches to Reducing Diagnostic and Treatment Delay in Colorectal Cancer.
Gorin SS
Ann Fam Med; 2019 Sep; 17(5):386-389. PubMed ID: 31501198
[No Abstract] [Full Text] [Related]
37. Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.
Lüchtenborg M; Morris EJA; Tataru D; Coupland VH; Smith A; Milne RL; Te Marvelde L; Baker D; Young J; Turner D; Nishri D; Earle C; Shack L; Gavin A; Fitzpatrick D; Donnelly C; Lin Y; Møller B; Brewster DH; Deas A; Huws DW; White C; Warlow J; Rashbass J; Peake MD
Thorax; 2018 Apr; 73(4):339-349. PubMed ID: 29079609
[TBL] [Abstract][Full Text] [Related]
38. Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.
Eden M; Harrison S; Griffin M; Lambe M; Pettersson D; Gavin A; Brewster DH; Lin Y; Johannesen TB; Milne RL; Farrugia H; Nishri D; King MJ; Huws DW; Warlow J; Turner D; Earle CC; Peake M; Rashbass J
Cancer Epidemiol; 2019 Feb; 58():184-192. PubMed ID: 30639877
[TBL] [Abstract][Full Text] [Related]
39. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.
Rose PW; Rubin G; Perera-Salazar R; Almberg SS; Barisic A; Dawes M; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Konrad G; Toftegaard BS; Thulesius H; Vedsted P; Young J; Hamilton W; ;
BMJ Open; 2015 May; 5(5):e007212. PubMed ID: 26017370
[TBL] [Abstract][Full Text] [Related]
40. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).
Menon U; Vedsted P; Zalounina Falborg A; Jensen H; Harrison S; Reguilon I; Barisic A; Bergin RJ; Brewster DH; Butler J; Brustugun OT; Bucher O; Cairnduff V; Gavin A; Grunfeld E; Harland E; Kalsi J; Knudsen AK; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Weller D
BMJ Open; 2019 Nov; 9(11):e025895. PubMed ID: 31776134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
